Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

76 results about "Dspe peg" patented technology

Mitochondrion-targeting nano-drug delivery system and preparation method and application thereof

The invention discloses a mitochondrion-targeting nano-drug delivery system, comprising polyethylene glycol connected with TPP and thioketal linker connected with a chemotherapeutic drug, the polyethylene glycol and the thioketal linker are connected with each other through amino and carboxyl condensation. This system also comprises DSPE-PEG and a photosensitizer; the chemotherapeutic drug forms a hydrophobic core inside, a hydrophilic shell layer is formed in the center of the polyethylene glycol, a mitochondrion-targeting crown is formed outside the TPP, and the photosensitizer is of hydrophobic structure distributed inside the core and / or around the core. TPP is selectively positioned to mitochondrion. This system is ROS responsive, the photosensitizer is laser excited to release ROS, and ROS cuts the thioketal linker to release the chemotherapeutic drug and can carry out photodynamic therapy at the same time, thus enabling synergic therapy of mitochondrion-targeting photodynamic therapy and chemotherapy. The invention also discloses a preparation method and application of the mitochondrion-targeting nano-drug delivery system.
Owner:SHANGHAI JIAO TONG UNIV

Folate-targeted reduction sensitive drug-carrying polymer nano-micelle as well as preparation method and application thereof

The invention relates to a folate-targeted reduction sensitive drug-carrying polymer nano-micelle as well as a preparation method and application thereof. The delivery carrier is prepared by taking anamphiphilic triblock copolymer PCL-ss-PEG-ss-PCL as a material, and a chemotherapeutic drug adriamycin amycin and a photosensitizer indocyanine green are entrapped in a hydrophobic core of the micelle. Besides, phospholipid DSPE-PEG-NH2 with an active group is introduced into the preparation process, the DSPE end of the phospholipid has strong hydrophobic property and is inserted into the hydrophobic PCL core of the polymer micelle, the flexible hydrophilic PEG long chain exists on the outer surface of the micelle, FA with a targeting effect is connected to a PEG active distal end of the surface of the polymer micelle, and functions of active tumor targeting and reduction response drug release are integrated. The folate-targeted reduction sensitive drug-carrying polymer nano-micelle disclosed by the invention has the advantages of being small in particle size, high in dispersion property, high in drug loading capacity and encapsulation efficiency and excellent in photothermal conversion effect, can realize reduced trigger drug release, fluorescence imaging of tumor sites, tumor targeting drug delivery and chemotherapy-photothermal combination therapy and improve the tumor inhibition effect, and has wide application prospects in the targeted combination therapy aspect of tumors.
Owner:INST OF BIOMEDICAL ENG CHINESE ACAD OF MEDICAL SCI

PH/reduction dual-sensitive multifunctional nano-micelle for tumor chemotherapy and photothermal combined therapy and application of pH/reduction dual-sensitive multifunctional nano-micelle

InactiveCN108354901AReduction-sensitiveWith pH/reduction smart responsivenessOrganic active ingredientsEnergy modified materialsDispersityTumor target
The invention relates to a pH / reduction dual-sensitive multifunctional nano-micelle for tumor chemotherapy and photothermal combined therapy and application of the pH / reduction dual-sensitive multifunctional nano-micelle. The pH / reduction dual-sensitive multifunctional nano-micelle is characterized in that a PCL-acetal-PEG polymer with pH sensitive characteristic, a PCL-ss-PEG-ss-PCL polymer withreduction sensitive characteristic and a phospholipid DSPE-PEG-NH2 with an active group are used as raw materials and are blended to prepare a pH / reduction intelligent responsive polymer nano-micelleas a carrier; a chemotherapeutic drug and a photosensitizer coat a hydrophobic core of the micelle; a casing is made of hydrophilic PEG and has the characteristic of long circulation and space stability; a folic acid targeting group is modified on the surface of the micelle by a covalent bond; the drug loading capacity is 4 to 10 percent, and the mass ratio of the chemotherapeutic drug to the photosensitizer is 0.5 to 2; the particle size is smaller than 200 nm. The pH / reduction dual-sensitive multifunctional nano-micelle disclosed by the invention has the advantages of good dispersity, smallparticle size, better photothermal conversion effect and high drug loading capacity and encapsulation efficiency; the effect of improving tumor suppression by tumor targeted administration, fluorescence imaging of a tumor site, pH / reduction triggered drug release and chemotherapy and photothermal combined therapy can be realized; the pH / reduction dual-sensitive multifunctional nano-micelle has a broad clinical application prospect in combined targeting therapy of tumors.
Owner:INST OF BIOMEDICAL ENG CHINESE ACAD OF MEDICAL SCI

Nanoparticle and preparation method thereof

The invention relates to a nanoparticle and a preparation method thereof. Poly(lactide-glycolide acid) (PLGA) is in the center to serve as a core, phospholipid surrounds the surface of the PLGA core in monolayer and distearoyl phosphatidylethanolamine-polyethyleneglycol-carboxyl (DSPE-PEG-COOH) penetrates the monolayer phospholipid to serve as the shell. The phospholipid, the DSPE-PEG-COOH and the PLGA have good biocompatibility, can entrap hydrophobic drugs and control the drugs to release slowly in the human bodies. The phospholipid surrounds the surface of the PLGA, thus ensuring that the particle can avoid immune system recognition so that the circulating half life of the particle is lengthened. The PEG shell ensures the particle to have spatial stability, static stability, long circulation and other characteristics and to be not easily agglomerated. Meanwhile, carboxyl is easily crosslinked with such ligands as antibodies, peptide, probes and the like, thus ensuring the particle to have targeting characteristic. The preparation method of the nanoparticle is simple, convenient practical and is easy to operate and popularize.
Owner:SHENZHEN INST OF ADVANCED TECH

Multifunctional nano probe for multimodal images and photothermal therapy of liver cancer and application of multifunctional nano probe

The invention provides an Au-ICG (gold-indocyanine green) lipidosome multifunctional nano probe and application thereof. The nano probe consists of a kernel and a shell, wherein the kernel is a nanogold particle of which the surface is wrapped with a poly-dopamine layer and adsorbs indocyanine green; the shell is a DSPE-PEG (distearoyl phosphatidyl ethanolamine-polyethylene glycol) lipidosome film which is coupled with lactobionic acid and is chelated with Gd<3+> ions. The Au-ICG lipidosome multifunctional nano probe disclosed by the invention can be used for various image modes such as MRI (nuclear magnetism imaging), CT (computed tomography) imaging and near infrared fluorescence imaging of the liver cancer; a patient only needs to stand medicine supplying of a contrast agent, and various diagnosis effects can be achieved; furthermore, by virtue of the improvement of the sensitivity, the using amount of the contrast agent can be reduced, so that the toxic and side effect is further relieved; under near infrared illumination at 808 nm, adsorbed ICG molecules can effectively convert light energy into heat energy to produce superhigh heat of 60-70 DEG C, so that liver cancer cells can be killed thermally; therefore, the multifunctional nano probe can be used as a multimodal contrast agent for liver cancer diagnosis and can be used as a photothermal therapy agent for the liver cancer.
Owner:FUZHOU HOSPITAL FOR INFECTIOUS DISEASE

DSPE-PEG-FA-modified nanometer paclitaxel liposome and preparation method thereof

The invention relates to a DSPE-PEG2000-FA-modified nanometer paclitaxel liposome. A molar ratio of the DSPE-PEG2000-FA to egg yolk lecithin is 0.05% to 0.15%, and a particle size of the liposome is less than 150 nm. A preparation method of the DSPE-PEG2000-FA-modified nanometer paclitaxel liposome comprises the following steps: first, preparing a DSPE-PEG2000-FA into a DSPE-PEG2000-FA micelle; second, performing incubation on the phosphatidyl ethanolamine-polyethylene glycol2000-folic acid micelle and a paclitaxel liposome together to obtain a DSPE-PEG2000-FA-modified nanometer paclitaxel liposome. Materials, which are forbidden to be used in clinical practice, are not used as crude materials in the present invention. According to the invention, the DSPE-PEG2000-FA-modified nanometer paclitaxel liposome has a small particle size, and the content of the DSPE-PEG2000-FA is low; besides, the DSPE-PEG2000-FA-modified nanometer paclitaxel liposome has good drug entrapment efficiency and good colloid stability. Moreover, the DSPE-PEG2000-FA-modified nanometer paclitaxel liposome can be absorbed effectively by an ovarian cancer cell having properties of sensitiveness to folic acid (+) and drug resistance, and the cytotoxicity of folic acid dependence is displayed; therefore, the efficacy of the DSPE-PEG2000-FA-modified nanometer paclitaxel liposome is stronger than that of a paclitaxel injection.
Owner:李红霞

Reductively-responsive paclitaxel prodrug and preparation method for nano-micelle carrier

The invention discloses a reductively-responsive paclitaxel prodrug. The reductively-responsive paclitaxel prodrug is synthesized from paclitaxel (PTX) and dithiodicarboxylic acid in a mol ratio of 2: 1 through covalent combination via an ester bond, and the molecular structure of the synthesized paclitaxel prodrug is PTX-SS-PTX. A PTX prodrug nano-micelle carrier is mainly composed of PTX-SS-PTX and distearoyl-phosphatidylethanolamine-polyethylene glycol (DSPE-PEG). According to the PTX-SS-PTX prodrug in the invention, a disulfide bond can rotate freely; and on the condition that the paclitaxel prodrug and a paclitaxel prodrug nano-micelle drug delivery system provided by the invent are stimulated by a high-concentration glutathione reductive environment in tumor cells, the disulfide bond breaks, and a parent drug is released. The reductively-responsive paclitaxel prodrug can obviously improve the drug loading capacity and encapsulation efficiency of PTX and improves stability of a PTX nanometer drug delivery system.
Owner:NANJING MEDICAL UNIV

Preparation method of radiation sensitive copolymer carrier for coating radiated nanoparticles and chemotherapy drugs

The preparation method of radiation-sensitive copolymer carrier for coating radiated nanoparticles and / or chemotherapy drugs includes forming a nanosphere by diselenide block copolymers and DSPE-PEG-biomarkers to coat chemotherapy drugs and / or radiated nanoparticles that can be released from the opened nanosphere by protons penetrating tissue during proton therapy. The treatment effect of proton therapy is enhanced by two ways of using the radiated nanoparticles released from an opened nanosphere to produce nuclear fission with the protons for releasing electrons to destroy cancer cells of tumor and the chemotherapy drugs released from the opened nanosphere for distributing among tissue to kill the cancer cells of the tumor.
Owner:INST OF NUCLEAR ENERGY RES NUCLEAR ENERGY COUNCIL EXECUTIVE YUAN

Tumor-targeted delivery carrier based on cell-derived micro-vacuoles, preparation method and application

The invention discloses a tumor-targeted delivery carrier based on cell-derived micro-vacuoles, a preparation method and an application. The preparation method comprises the following steps of: (A) preparing a conditioned medium: supplementing fetal bovine serum, antibiotics, DSPE-PEG-Biotin and DSPE-PEG-Folate into a basal medium; (B) using the obtained conditioned medium in cell culture, and collecting cell culture supernatant for subsequent separation; (C) carrying out low-speed centrifugation on the obtained culture supernatant to remove cell debris and apoptotic bodies, then adding SA-IONPs, mixing uniformly, incubating, then separating by a magnet, using PBS for re-suspension, eluting for multiple times to obtain the cell-derived micro-vacuoles with membrane surfaces modified by folic acid and iron oxide nano-particles, and freezing for storage; and (D) loading chemotherapeutic drugs or therapeutic genes into the functionalized micro-vacuoles doubly-modified by an electroporation mode, and carrying out re-suspension after separation with the magnet. The tumor-targeted delivery carrier based on cell-derived micro-vacuoles, the preparation method and the application disclosed by the invention are applicable to specific targeting delivery of multiple chemotherapeutic drugs and therapeutic genes, and have the advantages of enhancing the anti-tumor effect, reducing the systemic toxicity and improving the clinical effect of the current therapeutic selection, so that a new hope is brought for clinical therapy of tumors.
Owner:珈泌生物科技(武汉)有限责任公司

Preparation method and application of functional erythrocyte membrane

InactiveCN109316604AGood biocompatibilityOvercome the defects that cannot be avoided by the body's immune clearanceCosmetic preparationsEnergy modified materialsErythrocyte membranePhosphate
The invention discloses a preparation method of a functional erythrocyte membrane. The preparation method is characterized in that 0.6 mg of erythrocyte membrane is dissolved into 1 ml of deionized water or phosphate buffer liquid, wherein the phosphate buffer liquid is NaH2PO4 and Na2HPO4, the pH (potential of Hydrogen) value is 7.4, and the concentration is 100 mM; and a membrane solution and DSPE-PEG-RGD are subjected to ultrasonic wave or stirring, and the functional erythrocyte membrane can be obtained. The preparation method is easy to operate, the final functional erythrocyte membrane can serve as a carrier material to transport drugs or biological molecules to conduct medical and cosmetology and serves as a decoration camouflage material to coat the surface of other materials to realize decoration and camouflage, accordingly, accumulation of nano materials or active biological molecules at specific parts is improved, and the treatment and application effects are enhanced.
Owner:武汉市卉研生物科技有限公司

Anti-tumor medicine coupler decorated with saturated fatty acid and self-assembling nanometer system and preparation method of anti-tumor medicine coupler

The invention relates to an anti-tumor medicine coupler decorated with saturated fatty acid and a self-assembling nanometer system and preparation method of the coupler. Firstly, the coupler obtained by decorating the structure of the anti-tumor medicine with different types of saturated fatty acid can be self-assembled into spherical nanoparticles uniform in granularity and high in stability in water; secondly, after any amphiphilic polymer material such as DSPE-PEG is added in the preparation process, the granularity of the self-assembled nanoparticles can be decreased, and the stability of the nanoparticles can be improved. By means of the method, the anti-tumor medicine where nanoparticles can hardly be self-assembled can be endowed with the self-assembling capacity, only one step of reaction is needed during synthesis, and the method is easy and convenient to implement; meanwhile, compared with a traditional carrier dependence type nanometer system and an amphiphilic prodrug micelle system, the self-assembling system has higher medicine loading capacity and higher stability; the preparation method is easier to implement and beneficial to industrial production and provides a new concept for design and establishment of nanometer medicines.
Owner:PEKING UNIV

Acetylation sugar ester-polyethylene glycol-phosphatidyl ethanolamine conjugate and preparation method and application thereof

The invention discloses acetylation sugar ester-polyethylene glycol-phosphatidyl ethanolamine conjugate and a preparation method and application thereof. The acetylation sugar ester-polyethylene glycol-phosphatidyl ethanolamine conjugate is named as distearoyl-phosphatidylethanolamine-polyethylene glycol-p-p-carboxy phenyl-gamma-acid-alpha-D-acetylmannosamine (DSPE-PEG-Ac4MAN), and the acetylationsugar ester-polyethylene glycol-phosphatidyl ethanolamine conjugate has the structure shown in the formula I. In addition, the invention further provides brain-targeted liposome comprising the acetylation sugar ester-polyethylene glycol-phosphatidyl ethanolamine conjugate. A pharmacodynamic test proves that the liposome can have the 'prodrug' effect in a body, through the effect of hydrolytic enzymes in the body, cell uptake and body interior activity of drugs are improved, and the good killing activity on C6 / U87 cells is achieved. A brain-targeted drug is prepared through drug-containing arsenic trioxide (arsenic trioxide), the purpose that the arsenic trioxide crosses the blood-brain barrier to treat glioma is achieved, and the survival time of mice is obviously prolonged. A new technical means is provided for treatment of brain glioma.
Owner:HARBIN MEDICAL UNIVERSITY

Irinotecan hydrochloride nanometer fat beam preparation and preparation method thereof

The invention discloses an irinotecan hydrochloride nanometer fat beam preparation, which comprises an entrapment material, and irinotecan hydrochloride and a water-based solvent for injection, wherein the entrapment material is one or at least two of PLGA-PEG, PGA-PEG, PCL-PEG, PEG-NH2, PEG-COOH, DSPE-PEG, Solutol HS15, and phospholipid. The invention also discloses a preparation method for the irinotecan hydrochloride nanometer fat beam preparation and irinotecan hydrochloride nanometer fat beam powder preparation prepared by the method. The encapsulation efficiency of the irinotecan hydrochloride nanometer fat beam preparation reaches up to 85%, the grain size of the irinotecan hydrochloride nanometer fat beam preparation is about 10nm, and the irinotecan hydrochloride nanometer fat beam preparation can realize passive target to tumors and can increase pharmacological function and reduce the toxic and side effects of the system. The irinotecan hydrochloride nanometer fat beam powder preparation improves the safety and compliance of the irinotecan hydrochloride preparation, lowers the toxicity of the irinotecan hydrochloride, and prolongs the circulation time in the body. The preparation method is simple and feasible, has good repeatability, and is applicable to industrial production.
Owner:THE NAT CENT FOR NANOSCI & TECH NCNST OF CHINA

Sugar-polyethylene glycol-DSPE (1,2-distearoyl-sn-glycero-3-phosphoethanolamine) conjugated compound and preparation method and application thereof

The invention discloses sugar-polyethylene glycol-DSPE (1,2-distearoyl-sn-glycero-3-phosphoethanolamine) conjugated compound and a preparation method and application thereof, wherein the sugar-polyethylene glycol-DSPE conjugated compound is prepared by conjugating sugar to DSPE-PEG (polyethylene glycol). The sugar is one of a monosaccharide, a disaccharide, a polysaccharide and the sugar acetylated, wherein the monosaccharide includes mannose, galactose, arabinose and glucose; the disaccharide includes maltose; the polysaccharide is maltotriose. DPSE is artificial phospholipid, having lipotropism; PEG is a hydrophilic substance; a sugar ligand is a target of a targeting material. The compound herein is applicable to the design of targeting carriers, especially liposomes and micelles, and is also applicable as a surfactant. In addition, the invention also provides the preparation method of the compound herein; materials for the preparation method are easy to attain, reaction conditionsare mild and easy to control, the preparation method is simple to perform, the product is easy to purify, and the yield is high. The product is applicable to biological researches and is important tothe preparation of drug carriers and the disease treatment.
Owner:HARBIN MEDICAL UNIVERSITY

Preparation method of magnetic resonance contrast agent targeting blood-brain barrier and glioma

The invention discloses a preparation method of a magnetic resonance contrast agent targeting blood-brain barrier and glioma. The method comprises the following steps of dispersing ferric chloride hexahydrate and sodium oleate in a mixture of ethanol, water and n-hexane to obtain precursor iron oleate; dissolving the precursor in a mixed solution of oleoyl alcohol and diphenyl ether, and stirringthe mixture at about 110 DEG C under nitrogen protection; rising the temperature to about 200 DEG C under nitrogen protection, and carrying out reflux to obtain an oil acid-coated ferroferric oxide nanoparticles; and dispersing the nanoparticles in trichloromethane, adding excess DSPE-PEG-Maleimide for hydrophilic modification, dispersing the modified ferroferric oxide nanoparticles in PBS, and finally grafting specific glioma-targeted molecules Angiopep-2. The magnetic resonance contrast agent can efficiently cross the blood-brain barrier, and can be used as a novel type of magnetic resonanceimaging positive contrast agent for early diagnosis and boundary definition of glioma.
Owner:AFFILIATED HUSN HOSPITAL OF FUDAN UNIV

Taxol liposome preparation with active tumor targeting function as well as preparation method and application thereof

The invention discloses a taxol liposome preparation with an active tumor targeting function. The preparation is prepared from taxol, egg yolk lecithin, cholesterol, phosphatidylethanolamine pegol, tbFGF-PEG-DSPE (truncated basic fibroblast growth factor-polyethylene glycol-distearoyl phosphatidylethanolamine) and injection water. According to the preparation, tbFGF capable of being specifically combined with tumor cells and tumor angiogenic blood vessels and maleinimide-polyethylene glycol-phospholipid (DSPE-PEG-MAL) are chemically coupled, thus preparing the tbFGF-PEG-DSPE, and a liposome is prepared from a coupling product and wraps the taxol, thus building a liposome dosage form with long circulation and active tumor targeting functions; therefore, the active tumor targeting and tumor resisting effects are enhanced.
Owner:SICHUAN PROVINCIAL PEOPLES HOSPITAL

Carbon nano tube complex gene vector system and preparation method thereof

The invention discloses a carbon nano tube complex gene vector system, and researches the effectiveness, biocompatibility, cytotoxicity, transfection efficiency and the like of the carbon nano tube complex gene vector system. Polyethyleneimine-cholesterol (PEI-Chol) and polyethylene glycol-distearoyl phosphatidyl ethanolamine (DSPE-PEG) are combined on the wall of the carbon nano tube through hydrophobic interaction, so as to obtain the carbon nano tube complex gene vector system. The preparation method comprises specific steps of (1) synthesizing polyethyleneimine-cholesterol by using polyethyleneimine and cholesteryl chloroformate through a dehydrating agent triethylamine under anhydrous low temperature condition; (2) obtaining the water-soluble positive ion carbon nano tube complex system by using polyethyleneimine-cholesterol and polyethylene glycol-distearoyl phosphatidyl ethanolamine through ultrasonic dispersion. The carbon nano tube complex system can be steadily and uniformly dispersed in phosphate solution (pH=7.4), cell medium and serum in 24 hours, has low toxicity, effectively combines and concentrates DNA molecules, and has high transfection efficiency.
Owner:ZHEJIANG UNIV

Targeted fluorescent liposome based on low-frequency ultrasonic response, preparation method of liposome and application

The invention provides a targeted fluorescent liposome based on low-frequency ultrasonic response, a preparation method of the liposome and an application, and particularly provides an active targeting medicine carrying fluorescent acoustic liposome which comprises a bimolecular lamellar lipid membrane, medicines and fluorescent agents, wherein the bimolecular lamellar lipid membrane comprises dipalmitoyl phosphatidyl choline (DPPC), cholesterol (CHO), polyethylene glycol modified distearoyl phosphoethanolamine (DSPE-PEG) and (DSPE-PEG-iRGD), and the acoustic liposome wraps the medicines and the fluorescent agents. The medicines are selected from methotrexate (MTX), the fluorescent agents are selected from indocyanine green (ICG), and polyethylene glycol (PEG) in the polyethylene glycol modified distearoyl phosphoethanolamine (DSPE-PEG) is selected from PEG1000-PEG3000.
Owner:GUANGDONG NO 2 PROVINCIAL PEOPLES HOSPITAL

Preparation and application of tumor-targeting drug based on unsaturated fatty acid nanoparticles

The invention discloses preparation and application of a tumor-targeting drug based on unsaturated fatty acid nanoparticles. Carboxyl groups of docosahexaenoic acid and amino groups of amino polyethylene glycol are subjected to a condensation reaction to prepare a micelle mPEG-DHA; carboxyl groups of DSPE-PEG-COOH and amino groups of Anti-HER2 are subjected to a condensation reaction to prepare amicelle DSPE-PEG-Anti-HER2; the micelle mPEG-DHA, the micelle DSPE-PEG-Anti-HER2, pyropheophorbide-a methyl ester and adriamycin are subjected to self-assembly to obtain the targeting nanoparticles DPSPAH / MPPa / DOX used for lipid peroxidation and photodynamic-chemotherapy combined tumor therapy. The nanoparticles DPSPAH / MPPa / DOX have a particle size of about 190 nanometers and good stability, can effectively control the release of chemotherapeutic drugs, have good biocompatibility, high efficiency, low toxicity and higher application prospects in the fields of nano drug carriers and nano drug tumor treatment.
Owner:SOUTH CHINA NORMAL UNIVERSITY

Hydrophobic drug entrapped lipid-polymer with dual functions of targeting and radiosensitivity as well as preparation method and application of lipid-polymer

The invention discloses a hydrophobic drug entrapped lipid-polymer with dual functions of targeting and radiosensitivity. The lipid-polymer comprises lipid molecules with a targeting function, a poly-nitroimidazole organic polymer with radiosensitivity and a hydrophobic anti-cancer drug, wherein the lipid molecules (DSPE-PEG-target) with the targeting function, soybean lecithin and DSPE-PEG are prepared from polypeptide and targeting molecules with the targeting function in the lipid molecules through chemical reactions, the hydrophobic poly-nitroimidazole organic polymer is prepared from functional groups, namely nitroimidazole, with the radiosensitivity under the action of polymerization, and the polymer is prepared from the targeting lipid molecules, the soybean lecithin, the poly-nitroimidazole organic polymer and the hydrophobic anti-cancer drug through hydrophilic / hydrophobic compounding. The radiosensitivity is improved, the synergetic treatment effects of radiotherapy and chemotherapy upon tumor are improved, and a toxic and side effect reduction function is achieved; and a synchronous treatment function of radiotherapy sensitizers and anti-cancer medicine molecules is achieved, and clinical practicability and practical treatment significances can be achieved.
Owner:XUZHOU MEDICAL UNIV

Nano-particle with excellent blood stabilizing performance, and preparation method thereof

The invention belongs to the technical field of nano-medicines, and provides a nano-particle with an excellent blood stabilizing performance, and a preparation method thereof. Poly(glycolide-co-lactide) (PLGA), a medicine / probe molecule, distearoyl phosphoethanolamine-polyethylene glycol-maleimide (DSPE-PEG) and pluronic F127 (PF127) which are used as raw materials undergo a rapid nanoprecipitation technique to prepare the nano-particle having the advantages of controlled particle size, good monodispersity, and excellent stability and performances in various solutions. A large number of hydroxyl groups and negative charges on the surface of the particle have a protection effect, so the nano-particle do not bind to proteins in serum, thereby the protein is avoided from being absorbed and metabolized by the reticuloendothelial system; and the hydrophobic medicine and the hydrophobic or amphipathic probe are encapsulated, so the particle can significantly prolong the blood circulation half-life of the medicine and the probe, and provides a good medicine delivery platform for disease detection and treatment.
Owner:SUN YAT SEN UNIV

Preparation method for nanoparticles with small particle size and nanoparticle medicine carrier

The invention relates to the nano-medicine field, and concretely discloses a preparation method for nanoparticles with small particle size and an obtained nanoparticle medicine carrier. The method comprises steps: preparation of solutions, PLGA is dissolved in acetonitrile, and phosphatidylcholine bilayer and DSPE-PEG are dissolved in aqueous solutions of ethanol respectively; phosphatide film formation: the phosphatidylcholine bilayer solution and the DSPE-PEG solution are mixed, subjected to ultrasonic treatment and mixed uniformly, the solvents are removed, and phosphatide films are formed; nano-precipitation self assembly: the PLGA solution is added in the film-formed container, after mixing, the mixture is kept at the temperature of 60-65 DEG C with heat preservation, thus the PLGA and phosphatide are subjected to nano-precipitation self assembly for nanoparticles; and ultrafiltration collection: the nanoparticles are obtained after ultrafiltration centrifugation and collection. The preparation method is simple. The surfaces of the obtained nanoparticles with small particle size are charged negatively, and the nanoparticles have strong tumour penetrability and high cycling stability in organism. The nanoparticle can load various hydrophobic, hydrophilic and amphipathic medicines s as a medicine carrier and can be used widely.
Owner:SHENZHEN INST OF ADVANCED TECH

Nano probe having apoptosis targeting function as well as preparation method and application of nano probe

The invention relates to a nano probe having an apoptosis targeting function as well as a preparation method and an application of the nano probe. The MNPs DSPE PEG DPA Zn nano probe is composed of Fe@Fe3O4 nanoparticles, liposomes DSPE PEG coupled on the surface layers of the Fe@Fe3O4 nanoparticles and DPA Zn modified liposomes, wherein the prepared nano probe MNPs DSPE PEG DPA Zn is applicable to tumor apoptosis MRI (magnetic resonance imaging). In comparison with the prior art, the nano probe provided by the invention has the advantages that annexin or related polypeptides are replaced by cheap DPA-Zn, the DPA-Zn is grated to the surfaces of the nanoparticles by virtue of a simple and convenient non-catalysis Click reaction, tum apoptosis is detected by virtue of a non-invasive MRI means, and the like.
Owner:SHANGHAI NORMAL UNIVERSITY

Rupturable PEG modified adriamycin liposome preparation method

The invention belongs to the technical field of medicines, particularly relates to an adriamycin liposome preparation method and provides an adriamycin liposome preparation method with a function of improving tumor accumulation and tumor cell entering efficiency. The method includes the steps: (1) putting prescribed SPC, Cho, DSPE-PEG-TAT, DSPE-PEG-OMe into a 50ml eggplant-shaped flask, dissolving in chloroform, performing rotary evaporation to form a membrane, staying overnight in a vacuum drier, and adding 2.5ml of PBS buffer solution; (2) sucking dry a lipid material to form a membrane, adding 1ml of ammonium sulfate buffer solution, and ultrasonically hydrating to prepare uniform single unilamellar vesicles; (3) eluting the 1ml of single unilamellar vesicles with a certain buffer solution, replacing an external water phase through a gel column, and incubating at a certain temperature to obtain adriamycin liposome.
Owner:孙仁

Tumor targeted mitomycin C and MTX (methotrexate) double-drug preparation and preparation method thereof

The invention relates to the field of medical anti-tumor drug preparations, in particular to a tumor targeted mitomycin C and MTX (methotrexate) double-drug preparation for preventing malignant tumor growth and recurrence and a preparation method of the double-drug preparation. The tumor targeted mitomycin C and MTX double-drug preparation comprises a crude drug of mitomycin C, a carrier material and an MTX prodrug with targeting and anti-cancer functions, wherein the carrier material adopts lecithin and DSPE-PEG (distearoyl phosphoethanolamine-polyethylene glycol), and the MTX prodrug adopts DSPE-PEG-MTX. The tumor targeted mitomycin C and MTX double-drug preparation is spherical, has the grain diameter distributed between 20 nm and 80 nm, is suitable for being used as an intravenous injection preparation and has the characteristics of high targeting, long circulation, low toxicity and collaborative treatment.
Owner:XIAMEN CHITOSAN BIO TECH

Kit for preparation of nano-targeted liposome drug in combined radionuclide therapy and chemotherapy

InactiveUS20080226546A1Simple and convenient and effectiveSimple and convenient and effective and easyOrganic active ingredientsRadioactive preparation carriersCholesterolDspe peg
This invention is to manufacture a kit for preparation of nano-targeted liposome drugs in combined chemotherapy and radionuclide therapy. It is a kit consisting of three components: (1) A 10 ml vial A which contains BMEDA, gluconate acetate, SnCl2. (2) A 10 ml vial B which contains DSPC, cholesterol, DSPE-PEG, and Doxorubicin(DXR) (or Daunorubicin, Vinolbine). (3) A 10 ml vial C which contains 188ReO4− (or 186ReO4−) solution. The procedure of using the kit is as follows: (1) Remove the contents of the 188ReO4− (or 186ReO4−) solution from vial C. (2) Inject the 188ReO4− (or 186ReO4−) solution into the vial A, and the mixtures react in appropriate temperature. (3) Remove the contents of the 188Re-BMEDA (or 186Re-BMEDA) solution from vial A. (4) Inject the 188Re-BMEDA (or 186Re-BMEDA) solution into the vial B, and the mixtures react in appropriate temperature. The reconstituted solution in the vial B is applied to combine bimodality radiochemotherapy for treatment of tumor and ascites.
Owner:INST NUCLEAR ENERGY RES ROCAEC +1

Cell binding peptide drug delivery system and compound for treating cancer and tumors

InactiveUS20140271814A1Low toxicityDosage amount can be reducedBiocideHeavy metal active ingredientsCell bindingPeptide drug
The present invention is a method and compound for treating cancer and tumors. The invention treats cancer by encapsulating certain cancer fighting drugs in a liposome. Peptides attached to the compound then guide the compound towards its target. During its journey, DSPE-PEG is used to stabilize the compound, to allow more time in the blood stream before losing effectiveness.
Owner:ANDRALI SHIVA

Brain-targeted drug delivery system for improving microenvironment of drug-resistant glioma and reverse drug resistance

The invention discloses a brain-targeted drug delivery system for improving the microenvironment of drug-resistant glioma and reverse drug resistance. A small molecular weight polyethyleneimine (PEI)was grafted onto the side chain of polyaspartic acid (PASP) via a disulfide bond to synthesize a new cationic polymer, PASP-g-PEI, for compression of siPD-L1. The complex formed by siPD-L1 and PASP-G-PEI is used as the core, and the lipid film composed of 2-deoxyglucose (Glu) modified distearoylphosphatidylethanolamine-polyethylene glycol (DSPE-PEG), cholesterol and dioleoylphosphatidylethanolamine (DOPE) is used as the outer shell. A core-shell lipid polymer nanoparticle TMZ / siPD-L1@GLPN (PASP-g-PEI) co-loaded with siPD-L1 and TMZ is prepared by thin film dispersion method. The nanoparticlespass through the blood-brain barrier and enter drug-resistant glioma cells via glucose transporter, release naked siPD-L1 and TMZ rapidly under the condition of high GSH concentration in the cytoplasmof drug-resistant glioma cells, silence the expression of PD-L1 in TMZ resistant glioma cells, block the PD-1 / PD-L1 pathway in TMZ resistant glioma cells, and activate the killing effect of body immune system on glioma. At the same time, the expression of MGMT is decreased and the sensitivity of TMZ resistant glioma cells to TMZ is increased. By the above two ways, the growth of drug-resistantglioma was inhibited.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products